Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Regencell Bioscience Holdings Ltd (RGC)

34.9   -0.69 (-1.94%) 01-16 04:42
Open: 34.77 Pre. Close: 35.59
High: 34.96 Low: 33.3
Volume: 15,627 Market Cap: 453M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 35.036 - 35.227 35.227 - 35.386
Low: 32.846 - 33.079 33.079 - 33.273
Close: 34.534 - 34.905 34.905 - 35.213

Technical analysis

as of: 2022-01-15 8:49:21 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 44.97     One year: 52.52
Support: Support1: 30.55    Support2: 25.63
Resistance: Resistance1: 38.50    Resistance2: 44.97
Pivot: 32.69
Moving Average: MA(5): 34.93     MA(20): 31.33
MA(100): 24.47     MA(250):
MACD: MACD(12,26): 2.40     Signal(9): 2.18
Stochastic oscillator: %K(14,3): 75.74     %D(3): 73.74
RSI: RSI(14): 60.41
52-week: High: 59.00  Low: 6.00  Change(%): 232.4
Average Vol(K): 3-Month: 3055  10-Days: 2211

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
RGC has closed below upper band by 28.3%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 28 Dec 2021
12 Healthcare Stocks That Trade At Premium To Their IPO Price - Nasdaq

Tue, 28 Dec 2021
Is Regencell Bioscience Holdings Ltd (RGC) Stock Worth a Buy Tuesday? - InvestorsObserver

Mon, 13 Dec 2021
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors - Business Wire

Mon, 22 Nov 2021
Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO - Yahoo Finance

Thu, 02 Sep 2021
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment - Yahoo Finance

Sun, 22 Aug 2021
Regencell Bioscience Shares Increased 204.13%: Why It Happened - Pulse 2.0

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 13
Shares Float (M) 2
% Held by Insiders 80.15
% Held by Institutions 0.16
Shares Short (K) 26
Shares Short P. Month (K) 25

Stock Financials

EPS -0.140
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.400
Profit Margin
Operating Margin
Return on Assets (ttm) -202.1
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.104
Qtrly Earnings Growth
Operating Cash Flow (M) -1
Levered Free Cash Flow (M) 0

Stock Valuations

PE Ratio -249.29
PEG Ratio
Price to Book value -87.25
Price to Sales
Price to Cash Flow -589.92

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.